drugset / Trial / NCT00714961

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction

NCT00714961

Phase 3 Completed 3491 enrolled Sanofi Bristol-Myers Squibb · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine if the combination of aspirin plus clopidogrel is more effective than aspirin alone in preventing another heart attack, chest pain, stroke or death in people who have already had a heart attack that was treated with fibrinolytic therapy.

Timeline

Start
2003-02
Primary completion
2005-01
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg
Background Aspirin Small molecule